Literature DB >> 2806492

Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease.

J Vestbo1, F V Rasmussen.   

Abstract

The predictive value of cough, mucus hypersecretion, breathlessness, chronic bronchitis and forced expiratory volume in one second (FEV1) for hospitalization and medication were examined in a random population sample of 876 men, 46-69 yrs of age. All of the men were examined in 1974 with interview and lung function tests. Information on hospitalization in the period 1977-1986 was obtained from the Danish National Patient Register, and information on drug usage was obtained from 567 men in a questionnaire survey ultimo 1985. FEV1 was a strong predictor of both hospitalization and medication. Respiratory symptoms were good predictors of hospitalization due to either respiratory disease in general (odds ratios 2.56-3.29), or chronic obstructive pulmonary disease (COPD), (odds ratios 4.16-5.75). They contained predictive values in addition to that provided by FEV1. Respiratory symptoms were good predictors of medication for airway obstruction, relative risks 3.56-4.70, and/or airway disease in general, relative risks 2.67-4.69. After controlling for FEV1, cough was still significantly associated with treatment for airway disease in general and both cough, mucus hypersecretion and chronic bronchitis were significantly associated with treatment for airway obstruction. We conclude that apart from FEV1, respiratory symptoms are independent predictors of hospitalization and medication due to respiratory disease.

Entities:  

Mesh:

Year:  1989        PMID: 2806492

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Long-term exposure to cement dust and later hospitalization due to respiratory disease.

Authors:  J Vestbo; F V Rasmussen
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

2.  Dyspnea during daily activities in chronic spinal cord injury.

Authors:  Noel F Grandas; Nitin B Jain; Joan B Denckla; Robert Brown; Carlos G Tun; Mary Ellen Gallagher; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2005-08       Impact factor: 3.966

3.  Predictive value of the single-breath nitrogen test for hospitalization due to respiratory disease.

Authors:  J Vestbo; K M Knudsen; F V Rasmussen
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Predictors of cardiopulmonary hospitalization in chronic spinal cord injury.

Authors:  Anthony C Waddimba; Nitin B Jain; Kelly Stolzmann; David R Gagnon; James F Burgess; Lewis E Kazis; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2009-02       Impact factor: 3.966

5.  Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Authors:  Joseph Seaman; Anthony C Leonard; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 6.  Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.

Authors:  J R Hurst; J A Wedzicha
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

7.  Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.

Authors:  Katayoun Bahadori; J Mark FitzGerald; Robert D Levy; Tharwat Fera; John Swiston
Journal:  Can Respir J       Date:  2009 Jul-Aug       Impact factor: 2.409

8.  Associations between vitamin D, adiposity, and respiratory symptoms in chronic spinal cord injury.

Authors:  Palak Walia; Rebekah L Goldstein; Merilee Teylan; Antonio A Lazzari; Jaime E Hart; Carlos G Tun; Eric Garshick
Journal:  J Spinal Cord Med       Date:  2017-10-09       Impact factor: 1.985

9.  Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Authors:  Akkelies E Dijkstra; Joanna Smolonska; Maarten van den Berge; Ciska Wijmenga; Pieter Zanen; Marjan A Luinge; Mathieu Platteel; Jan-Willem Lammers; Magnus Dahlback; Kerrie Tosh; Pieter S Hiemstra; Peter J Sterk; Avi Spira; Jorgen Vestbo; Borge G Nordestgaard; Marianne Benn; Sune F Nielsen; Morten Dahl; W Monique Verschuren; H Susan J Picavet; Henriette A Smit; Michael Owsijewitsch; Hans U Kauczor; Harry J de Koning; Eva Nizankowska-Mogilnicka; Filip Mejza; Pawel Nastalek; Cleo C van Diemen; Michael H Cho; Edwin K Silverman; James D Crapo; Terri H Beaty; David A Lomas; Per Bakke; Amund Gulsvik; Yohan Bossé; Ma'en Obeidat; M A Obeidat; Daan W Loth; Lies Lahousse; Fernando Rivadeneira; Andre G Uitterlinden; Andre Hofman; Bruno H Stricker; Guy G Brusselle; Cornelia M van Duijn; Uilke Brouwer; Gerard H Koppelman; Judith M Vonk; Martijn C Nawijn; Harry J M Groen; Wim Timens; H Marike Boezen; Dirkje S Postma
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 10.  Cough and its importance in COPD.

Authors:  Jaclyn Smith; Ashley Woodcock
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.